{"SPADE_UN_17453": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17453", "Peptide Name": "", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "RGDFK", "Sequence Length": 5, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "Mix", "Structure Description": "Not found", "Formula": "C18H32N8O6", "Mass": 621.69, "PI": 8.75, "Net Charge": 1, "Hydrophobicity": -1.9, "Half Life": "Mammalian:1 hourYeast:2 minE.coli:2 min", "Literature": [{"Title": "Design and synthesis of novel dual-cyclic RGD peptides for αvβ3 integrin targeting", "Pubmed ID": "30732943", "Reference": "Bioorg Med Chem Lett. 2019 Apr 1;29(7)896-900.", "Author": "Liu J, Cheng X, Tian X, Guan D, Ao J, Wu Z, Huang W, Le Z.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=30732943"}], "Frequent Amino Acids": "DFG", "Absent Amino Acids": "ACEHILMNOPQSTUVWY", "Basic Residues": 2, "Acidic Residues": 1, "Hydrophobic Residues": 1, "Polar Residues": 2, "Positive Residues": 2, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_06814", "Similarity": 1.0, "Sequence": "RGDF"}, {"SPADE_ID": "SPADE_N_07334", "Similarity": 1.0, "Sequence": "KKKKKKNKKLQQRGD"}, {"SPADE_ID": "SPADE_UN_15549", "Similarity": 1.0, "Sequence": "FKKLKKLFSKLWNWKGGRGD"}]}}}